436 related articles for article (PubMed ID: 19446835)
1. Expression of serotonin and its 5-HT1A receptor in canine cutaneous mast cell tumours.
Fröberg GK; Lindberg R; Ritter M; Nordlind K
J Comp Pathol; 2009; 141(2-3):89-97. PubMed ID: 19446835
[TBL] [Abstract][Full Text] [Related]
2. An immunohistochemical study of vitamin D receptor expression in canine cutaneous mast cell tumours.
Russell DS; Rassnick KM; Erb HN; Vaughan MM; McDonough SP
J Comp Pathol; 2010; 143(2-3):223-6. PubMed ID: 20334872
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical application of an antibody specific for human CD1a to the diagnosis of canine mast cell tumour.
Yhee JY; Hong SW; Yu CH; Doster AR; Blas-Machado U; Lyoo YS; Sur JH
J Comp Pathol; 2008 Jul; 139(1):40-6. PubMed ID: 18602642
[TBL] [Abstract][Full Text] [Related]
4. Impact of tumour depth, tumour location and multiple synchronous masses on the prognosis of canine cutaneous mast cell tumours.
Kiupel M; Webster JD; Miller RA; Kaneene JB
J Vet Med A Physiol Pathol Clin Med; 2005 Aug; 52(6):280-6. PubMed ID: 16050909
[TBL] [Abstract][Full Text] [Related]
5. Expression of Ki67, BCL-2, and COX-2 in canine cutaneous mast cell tumors: association with grading and prognosis.
Vascellari M; Giantin M; Capello K; Carminato A; Morello EM; Vercelli A; Granato A; Buracco P; Dacasto M; Mutinelli F
Vet Pathol; 2013 Jan; 50(1):110-21. PubMed ID: 22673539
[TBL] [Abstract][Full Text] [Related]
6. Nucleomorphometric analysis of canine cutaneous mast cell tumours.
Maiolino P; Cataldi M; Paciello O; Restucci B; De Vico G
J Comp Pathol; 2005; 133(2-3):209-11. PubMed ID: 16045919
[TBL] [Abstract][Full Text] [Related]
7. Serotonin and its 5-HT1 receptor in human mastocytosis.
Ritter M; El-Nour H; Hedblad MA; Butterfield JH; Beck O; Stephanson N; Holst M; Giscombe R; Azmitia EC; Nordlind K
Immunopharmacol Immunotoxicol; 2012 Aug; 34(4):679-85. PubMed ID: 22268664
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of a two-centimeter lateral surgical margin for excision of grade I and grade II cutaneous mast cell tumors in dogs.
Fulcher RP; Ludwig LL; Bergman PJ; Newman SJ; Simpson AM; Patnaik AK
J Am Vet Med Assoc; 2006 Jan; 228(2):210-5. PubMed ID: 16426187
[TBL] [Abstract][Full Text] [Related]
9. Steroid receptors in canine and human female genital tract tumours with smooth muscle differentiation.
Millán Y; Gordon A; de los Monteros AE; Reymundo C; de las Mulas JM
J Comp Pathol; 2007; 136(2-3):197-201. PubMed ID: 17362977
[TBL] [Abstract][Full Text] [Related]
10. All subunits of the interleukin-2 receptor are expressed by canine cutaneous mast cell tumours.
Meyer A; Gruber AD; Klopfleisch R
J Comp Pathol; 2013 Jul; 149(1):19-29. PubMed ID: 23276382
[TBL] [Abstract][Full Text] [Related]
11. CD25 is expressed by canine cutaneous mast cell tumors but not by cutaneous connective tissue mast cells.
Meyer A; Gruber AD; Klopfleisch R
Vet Pathol; 2012 Nov; 49(6):988-97. PubMed ID: 22446323
[TBL] [Abstract][Full Text] [Related]
12. The value of immunohistochemical expression of BAX in formulating a prognosis for canine cutaneous mast cell tumours.
Strefezzi Rde F; Kleeb SR; Xavier JG; Fukumasu H; Catão-Dias JL
J Comp Pathol; 2012 May; 146(4):314-9. PubMed ID: 21899858
[TBL] [Abstract][Full Text] [Related]
13. Tandem duplication of KIT exon 11 influences the proteome of canine mast cell tumours.
Schlieben P; Meyer A; Weise C; Bondzio A; Gruber AD; Klopfleisch R
J Comp Pathol; 2013 May; 148(4):318-22. PubMed ID: 22935087
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of cyclooxygenase-2 expression in canine mast cell tumours.
Prada J; Queiroga FL; Gregório H; Pires I
J Comp Pathol; 2012 Jul; 147(1):31-6. PubMed ID: 22079567
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of canine mast cell tumors for presence of estrogen receptors.
Larsen AE; Grier RL
Am J Vet Res; 1989 Oct; 50(10):1779-80. PubMed ID: 2508516
[TBL] [Abstract][Full Text] [Related]
16. Canine mast cell diseases.
Cook JE
Natl Cancer Inst Monogr; 1969 Aug; 32():267-83. PubMed ID: 4981716
[No Abstract] [Full Text] [Related]
17. Effect of chronic mild stress on serotonergic markers in the skin and brain of the NC/Nga atopic-like mouse strain.
Rasul A; El-Nour H; Blakely RD; Lonne-Rahm SB; Forsberg J; Johansson B; Theodorsson E; Nordlind K
Arch Dermatol Res; 2011 Nov; 303(9):625-33. PubMed ID: 21400247
[TBL] [Abstract][Full Text] [Related]
18. Advances in the diagnosis and management of cutaneous mast cell tumours in dogs.
Dobson JM; Scase TJ
J Small Anim Pract; 2007 Aug; 48(8):424-31. PubMed ID: 17559522
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical characterization of feline mast cell tumors.
Mallett CL; Northrup NC; Saba CF; Rodriguez CO; Rassnick KM; Gieger TL; Childress MO; Howerth EW
Vet Pathol; 2013 Jan; 50(1):106-9. PubMed ID: 22492208
[TBL] [Abstract][Full Text] [Related]
20. Synergistic antiproliferative effects of KIT tyrosine kinase inhibitors on neoplastic canine mast cells.
Gleixner KV; Rebuzzi L; Mayerhofer M; Gruze A; Hadzijusufovic E; Sonneck K; Vales A; Kneidinger M; Samorapoompichit P; Thaiwong T; Pickl WF; Yuzbasiyan-Gurkan V; Sillaber C; Willmann M; Valent P
Exp Hematol; 2007 Oct; 35(10):1510-21. PubMed ID: 17681669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]